Ransomware victim disclosure
← All victimsPrimeLink BioTherapeutics
listed as primelinkbio.com · Claimed by Lockbit5 · listed 5 hours ago
Status timeline
- ListedJun 20, 2026
- Data leakeddate unknown
At a glance
- Group
- Lockbit5
- Status
- Data leaked
- Country
- United States
- Sector
- Healthcare
- Listed on leak site
- Jun 20, 2026
About the victim
AI dossier — public-source company profilePrimeLink BioTherapeutics is a biotechnology company specializing in the development of Antibody-Drug Conjugates (ADCs), a class of targeted cancer therapeutics. The company focuses on innovative approaches to drug delivery in the biopharmaceutical sector.
- Industry
- Biotechnology & Pharmaceutical Development
Attack summary
Severity: high — Confirmed exfiltration of proprietary biotechnology research and business data from a pharmaceutical development company; ADC technology and development data represent significant competitive and intellectual property assets.LockBit5 claims to have compromised PrimeLink BioTherapeutics and exfiltrated company data. The post indicates data publication as part of the extortion campaign.
Data the group says was taken
AI dossier — extracted from the leak post- company documents
- business records
- proprietary research data
What the group claims
PrimeLink BioTherapeutics is an innovative ADC (Antibody-Drug Conjugate) biotechnology company dedic...
Sources
Source
Indexed 5 hours agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
Is this your supplier? Your competitor? You?
Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

